Gefitinib-resistant NSCLC cell lines exhibit elevated DDR1 expression, which regulates the miR-3648–SOCS2 axis, with SOCS2 acting as a positive modulator of ferroptosis. Here, DDR1 is linked to non-small cell lung carcinoma.